Serum levels of LPS are elevated in patients with NASH and animal models of NASH, suggesting that TLR4 is activated (Cani et al., 2007; Miele et al., 2009). The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatohepatitis.